Kenneth Allen Myszkowski, Chief Financial Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 25,008 shares at $34.97 ($885K) on 2024-01-05, disclosed to the SEC on 2024-01-08.
Scheduled sale ($885k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.04 | 1,400 | $48K | 5.4% |
| 2 | $34.97 | 5,800 | $203K | 22.9% |
| 3 | $35.65 | 8,904 | $317K | 35.9% |
| 4 | $35.65 | 8,904 | $317K | 35.9% |
| Total | $35.40 avg | 25,008 | $885K | 100% |
| Filing → |
| ARWR | SELL | 2023-06-29 | $543K | — | Filing → |
| ARWR | SELL | 2022-12-30 | $1.2M | — | Filing → |
| ARWR | SELL | 2022-01-06 | $2.9M | — | Filing → |